Clinical Trial

Protein-Distinct Macronutrient-Equivalent Diet 2

Study acronym: PRODMED2
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The central hypothesis is that the addition of minimally processed lean pork to a healthy plant-forward low ultra-processed diet will enhance nutrient adequacy, promote muscular fitness, and maintain metabolic functions for improved healthspan. A well-designed, randomized, controlled, crossover, feeding study with clinical and molecular mechanistic endpoints is proposed to provide the most definitive level of evidence logistically possible in humans and to establish the role of minimally processed lean pork in healthspan promotion. Utilizing an all-food-provided (dine-in and take-out) design over 18 weeks (rolling recruitment, 8+8, 2w washout), a comprehensive assessment of metabolomics, system biology, physical, and physiological markers that indicate the risk of age-related comorbidities-critical micronutrient deficiency, frailty, metabolic dysfunctions, and cognitive decline, is proposed in upper Midwesterners 65 years and older. A minimally processed plant-forward diet with or without added pork will be compared for over 250 outcome measures using mixed-effects modeling adjusting for covariates in R. n=15/diet/arm i.e., a total starting sample size of n=30 is proposed for 90% power.
Protocol Amendment History 8 amendments
This ClinicalTrials.gov record has been amended 8 times since 2022-10-12; most recent amendment 2025-02-14.
Status change: Recruiting → Active, Not Recruiting 2023-09-11
Status change: Not Yet Recruiting → Recruiting 2023-04-11
Trial Details
NCT Number NCT05581953
Lead Sponsor South Dakota State University
Conditions Healthy Aging
Enrollment 59 participants
Start Date 2022-11-15
Primary Completion 2023-12-20 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-02-17